Motivation: The high cost of drug discovery motivates the development of accurate virtual screening tools. Binding-homology, which takes advantage of known protein-ligand binding pairs, has emerged as a powerful discrimination technique. In order to exploit all available binding data, modelled structures of ligand-binding sequences may be used to create an expanded structural binding template library. Results: SPOT-Ligand 2 has demonstrated significantly improved screening performance over its previous version by expanding the template library 15 times over the previous one. It also performed better than or similar to other binding-homology approaches on the DUD and DUD-E benchmarks. Availability and Implementation: The server is available online at http://sparks
Introduction
Traditional structure-based virtual screening (SBVS) involves the sampling and scoring of possible binding modes in a process known as docking. Binding-homology modelling (BHM) is an alternative SBVS approach whereby unknown interactions may be inferred from a database of interacting protein-ligand pairs. In this approach, novel ligands for a target protein can be inferred from similarity to the ligands of template proteins that are structurally similar to the target.
FINDsite (Brylinski and Skolnick, 2008) , was the first method to demonstrate the power of the binding homology approach by using a global protein-protein structural alignment. This method was later improved by incorporating model structures in FINDsite-comb (Zhou and Skolnick, 2013) and local structure alignments in PoLi (Roy et al., 2015) . Recently, we developed SPOT-Ligand (Yang et al., 2016) based on a global alignment technique, SP align (Yang et al., 2012) , and the ligand-bound protein structures in the curated BioLiP database (Yang et al., 2013) . The improvement of SPOT-Ligand over FINDsite is mainly due to the ability of SPalign to better capture partial similarity between two proteins and thus provides a more accurate inference of functional similarity. Here we present SPOT-Ligand 2 by expanding the template library to include pairs in which protein structures can be reliably modeled. Performance of SPOT-Ligand 2 on the Directory of Useful Decoys (DUD and DUD-E) (Huang et al., 2006; Mysinger et al., 2012) benchmark demonstrated significant improvement over SPOTLigand.
Methods
In addition to BioLiP (Yang et al., 2013) , we have collected proteinligand binding data from ChEMBL (Bento et al., 2014) , DrugBank Applications Note (Wishart et al., 2006) and BindingDB (Gilson et al., 2016) . To ensure high-confidence interactions, we kept only those binding pairs with reported affinity <10mM (IC50, EC50, K d , or K i ). The representative sequence of each template protein cluster [90% by Cd-hit (Li and Godzik, 2006) ] without an experimental structure was modeled by SPARKS-X (Yang et al., 2011) . The expanded library has over 15 times the number of pairs compared to the previous iteration, with 52.6, 39.2, 6.4 and 1.8% contributed from ChEMBL, BindingDB, BioLiP and DrugBank, respectively. The scoring of each query pair, dataset separation and performance measure were unchanged from the original SPOT-Ligand. Details can be found in the supplementary information.
Results
A comparison of results from SPOT-Ligand 2, SPOT-Ligand, PoLi, FINDsite-comb and AutoDock Vina (Trott and Olson, 2010) on the DUD/DUD-E benchmarks can be found in Table 1 and  Supplementary Table S1 . SPOT-Ligand 2 shows 93% improvement in EF0.01 on the independent test set, DUD-E65, compared to the original version. An evaluation of SPOT-Ligand 2 across different protein classes can be found in Table S2 of supplementary information. The assessment of performance using individual component databases indicates that improvements are mostly contributed by the two largest sets, ChEMBL and BindingDB (detailed in Supplementary Tables S3 and S4 ). Consistent with previous results, SPOT-ligand 2 performs well on enzyme targets from the DUD-E benchmark with the best average logAUC% of 54.6 for the Kinase subset. Kinase targets, on average, identified over 190 000 binding pairs from the template library compared to less than 3500 for Other Enzymes. This abundance of binding data may explain the performance peak for Kinase targets (Liu et al., 2014) . The FAK1 target, in particular, benefits from an expanded template library, with logAUC% improving from 42.5 to 76.3. Figure 1 demonstrates the ability of the method to recover an inhibitor of FAK1 based on the binding profile inferred from a remotely homologous (<30% sequence identity) but structurally similar (SP-score ¼ 0.945) protein template.
SPOT-ligand 2 is available as a web-server at http://sparks-lab.org. The user must provide a query protein structure to be screened against DrugBank in default or a small user-supplied compound library (<500 compounds) in SMILES format. The significance of the score is evaluated based on average performance of all 102 DUD-E targets ( Supplementary Fig. S2 ). The method takes less than 1 hour on a single CPU to screen 6859 TYSY compounds from the DUD-E benchmark. [a] 7.9 4.1 3.0 9.0 PoLi [b] 9.6 4.8 3.4 -SPOT-Ligand 
